GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Marksans Pharma Ltd

Marksans Pharma Sets August 20 Record Date for Rs. 0.90 Dividend

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Jul 2026, 12:30 PM IST  ·  BSE ID: 04459788-8cb7-48f4-b4dc-c76f9bd692f8
View Original BSE Filing (PDF)
💡
In Simple Terms
Marksans Pharma will pay a final dividend of ₹0.90 per share for the last financial year, with August 20th as the date to check who gets it.
🤖 AI Summary
  • Record date for final dividend set as 20 August 2026.
  • Final dividend recommendation is ₹0.90 per equity share.
  • Dividend is for the financial year ended 31 March 2026.
  • AGM scheduled for 27 August 2026 to seek member approval.
  • Dividend payment, if approved, expected on or after 10 September 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Record Date for Dividend
20 August 2026
Final Dividend per Equity Share
₹0.90 (90%)
Financial Year Ended
31 March 2026
AGM Date
27 August 2026
Expected Dividend Payment Date
on or after 10 September 2026
🏢 How This Affects the Company
💰
Financial Impact
The dividend payout will reduce the company's distributable reserves and cash balance upon payment, subject to member approval.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required. Shareholders should ensure their holdings are in demat form before the record date.
👤
Who Is Affected
Shareholders holding equity shares as of 20 August 2026 will be eligible to receive the final dividend.
🔍
Management Signal
Management is signaling intent to return profits to shareholders through dividends, pending AGM approval.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM on 27 August 2026 for dividend approval.
Actual dividend payment on or after 10 September 2026.
Release of Annual Report for FY2026.
LOW RISK Dividend declaration is a standard corporate action with clear dates and amounts.
💡 Investor Takeaway
Marksans Pharma fixed 20 August 2026 as the record date for a final dividend of ₹0.90 per equity share for FY2025-26. The AGM is on 27 August 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Final dividend of ₹0.90 per equity share for FY2025-26 recommended.
📅 Company Track Record
Marksans Pharma had previously recommended a final dividend of ₹0.90 per share for FY2025-26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the record date for Marksans Pharma's dividend?
The record date for determining eligibility to receive the final dividend for FY2025-26 is fixed as 20 August 2026.
What is the final dividend amount declared by Marksans Pharma?
Marksans Pharma recommended a final dividend of ₹0.90 per equity share of face value ₹1 each for the financial year ended 31 March 2026.
When will the Marksans Pharma AGM be held?
The 34th Annual General Meeting of Marksans Pharma will be held on Thursday, 27 August 2026.
When will the dividend be paid by Marksans Pharma?
The final dividend, if approved at the AGM, will be paid on or after 10 September 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.